Shapiro Adam J, Davis Stephanie D, Ferkol Thomas, Dell Sharon D, Rosenfeld Margaret, Olivier Kenneth N, Sagel Scott D, Milla Carlos, Zariwala Maimoona A, Wolf Whitney, Carson Johnny L, Hazucha Milan J, Burns Kimberlie, Robinson Blair, Knowles Michael R, Leigh Margaret W
From the Department of Pediatrics, Montreal Children's Hospital, McGill University, Montreal, QC, Canada.
Department of Pediatrics, Riley Hospital for Children, Indiana University, Indianapolis, IN.
Chest. 2014 Nov;146(5):1176-1186. doi: 10.1378/chest.13-1704.
Motile cilia dysfunction causes primary ciliary dyskinesia (PCD), situs inversus totalis (SI), and a spectrum of laterality defects, yet the prevalence of laterality defects other than SI in PCD has not been prospectively studied.
In this prospective study, participants with suspected PCD were referred to our multisite consortium. We measured nasal nitric oxide (nNO) level, examined cilia with electron microscopy, and analyzed PCD-causing gene mutations. Situs was classified as (1) situs solitus (SS), (2) SI, or (3) situs ambiguus (SA), including heterotaxy. Participants with hallmark electron microscopic defects, biallelic gene mutations, or both were considered to have classic PCD.
Of 767 participants (median age, 8.1 years, range, 0.1-58 years), classic PCD was defined in 305, including 143 (46.9%), 125 (41.0%), and 37 (12.1%) with SS, SI, and SA, respectively. A spectrum of laterality defects was identified with classic PCD, including 2.6% and 2.3% with SA plus complex or simple cardiac defects, respectively; 4.6% with SA but no cardiac defect; and 2.6% with an isolated possible laterality defect. Participants with SA and classic PCD had a higher prevalence of PCD-associated respiratory symptoms vs SA control participants (year-round wet cough, P < .001; year-round nasal congestion, P = .015; neonatal respiratory distress, P = .009; digital clubbing, P = .021) and lower nNO levels (median, 12 nL/min vs 252 nL/min; P < .001).
At least 12.1% of patients with classic PCD have SA and laterality defects ranging from classic heterotaxy to subtle laterality defects. Specific clinical features of PCD and low nNO levels help to identify PCD in patients with laterality defects.
ClinicalTrials.gov; No.: NCT00323167; URL: www.clinicaltrials.gov.
运动性纤毛功能障碍可导致原发性纤毛运动障碍(PCD)、完全性内脏反位(SI)以及一系列左右侧缺陷,但除SI外PCD患者中其他左右侧缺陷的患病率尚未得到前瞻性研究。
在这项前瞻性研究中,疑似PCD的参与者被转诊至我们的多中心联盟。我们测量了鼻一氧化氮(nNO)水平,通过电子显微镜检查纤毛,并分析了导致PCD的基因突变。内脏位置被分类为:(1)正常位(SS),(2)SI,或(3)位置不明确(SA),包括内脏异位。具有典型电子显微镜缺陷、双等位基因突变或两者皆有的参与者被认为患有典型PCD。
在767名参与者(中位年龄8.1岁;范围0.1 - 58岁)中,305名被定义为患有典型PCD,其中分别有143名(46.9%)、125名(41.0%)和37名(12.1%)为SS、SI和SA。在典型PCD患者中发现了一系列左右侧缺陷,包括分别有2.6%和2.3%的SA患者伴有复杂或简单心脏缺陷;4.6%的SA患者无心脏缺陷;2.6%的患者有孤立的可能左右侧缺陷。与SA对照参与者相比,患有SA和典型PCD的参与者中PCD相关呼吸道症状的患病率更高(全年湿性咳嗽,P < .001;全年鼻塞,P = .015;新生儿呼吸窘迫,P = .009;杵状指,P = .021)且nNO水平更低(中位值,12 nL/分钟 vs 252 nL/分钟;P < .001)。
至少12.1%的典型PCD患者患有SA以及从典型内脏异位到细微左右侧缺陷的一系列左右侧缺陷。PCD的特定临床特征和低nNO水平有助于识别有左右侧缺陷的患者中的PCD。
ClinicalTrials.gov;编号:NCT00323167;网址:www.clinicaltrials.gov。